GGrantIndex
Sort

39,280 grants matching leukemia

Interferon Responses in Myeloid Leukemia

$312,379
Serge Y Fuchs · University Of Pennsylvania · R01 · FY2014 · CA

(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia

$312,377
Michael A. Farrar · University Of Minnesota · R01 · FY2015 · CA

Identification of Methylated Genes in Chronic Lymphocytic Leukemia

$312,371
Christoph Plass · Ohio State University · P01 · FY2009 · CA

PEDIATRIC ONCOLOGY GROUP

$312,366
Stanford University · U10 · FY2001 · CA

Population-Based Assessment of Cancer Trial Generalizability in the Elderly

$312,343
Elizabeth B Lamont · Harvard Medical School · R01 · FY2010 · CA

(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia

$312,341
Michael A. Farrar · University Of Minnesota · R01 · FY2016 · CA

MICRO RNA TARGETING OF NORMAL & LEUKEMIA STEM- PROGENITOR CELLS

$312,332
Curt I Civin · Johns Hopkins University · P01 · FY2012 · CA

(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia

$312,304
Michael A. Farrar · University Of Minnesota · R01 · FY2017 · CA

Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)

$312,288
Jing Zhang · University Of Wisconsin-Madison · R01 · FY2011 · CA

Development of JS-K as an anti-leukemic agent

$312,288
Paul J Shami · University Of Utah · R01 · FY2009 · CA

Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)

$312,288
Jing Zhang · University Of Wisconsin-Madison · R01 · FY2015 · CA

Development of JS-K as an anti-leukemic agent

$312,288
Paul J Shami · University Of Utah · R01 · FY2010 · CA

EWS/FLI AND ITS TARGETS IN EWING'S SARCOMA

$312,288
Stephen L Lessnick · University Of Utah · R01 · FY2010 · CA

The role of XMRV, a newly discovered human retrovirus, in cancer pathogenesis

$312,288
Ila R Singh · University Of Utah · R01 · FY2010 · CA

Molecular mechanisms of transcriptional regulation in the Notch pathway

$312,262
Rhett Kovall · University Of Cincinnati · R01 · FY2014 · CA

Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity

$312,246
William R. Drobyski · Medical College Of Wisconsin · R01 · FY2012 · DK

Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity

$312,246
William R. Drobyski · Medical College Of Wisconsin · R01 · FY2011 · DK

Assay Development for NSD1 Methyltransferase Inhibitor Discovery

$312,244
Edward Anders Kolb · Nemours Children'S Hospital, Delaware · R01 · FY2017 · CA

Assay Development for NSD1 Methyltransferase Inhibitor Discovery

$312,244
Andrew Napper · Nemours Children'S Hospital, Delaware · R01 · FY2016 · CA

Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia

$312,240
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA

Characterization of Myeloid Tumor Suppressor Genes on Chromosome 5

$312,195
Michelle M Le Beau · University Of Chicago · P01 · FY2011 · CA

MICROGLIA IN RETROVIRUS INDUCED NEURODEGENERATION

$312,187
William P Lynch · Northeast Ohio Medical University · R01 · FY2006 · NS

Mechanisms promoting translocations and mature B cell lymphomas

$312,164
Jing Hong Wang · University Of Colorado Denver · R01 · FY2014 · CA

Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis

$312,114
Ann Marie Pendergast · Duke University · R01 · FY2011 · CA

GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM

$312,110
Banner Good Samaritan Medical Center · U10 · FY2000 · CA